Firm Producing Unauthentic Bird Flu Vaccines Ordered to Suspend Production
Posted on: Friday, 11 November 2005, 09:00 CST
Firm producing unauthentic bird flu vaccines ordered to suspend production
HOHHOT, Nov. 10 (Xinhua) -- A Chinese pharmaceutical plant which had illegally produced and sold unauthentic bird flu vaccines was ordered to suspend operation Thursday.
The biological pharmaceutical plant, based in north China's Inner Mongolia Autonomous Region, was found producing at least 4 million ml. of triple vaccines against Newcastle disease and H9N2 and H5N28 types of bird flu between May and June this year without government approval, according to the regional agricultural department.
The vaccines had been sold to Liaoning and Henan provinces. Investigators found that the vaccines were products from pilot- scale production, which were allowed to be used in experiments but have not been approved for sale.
Operation of the plant, which was approved by the Ministry of Agriculture for the production of livestock vaccines, has stopped.
The ministry allowed the plant to make a type of H5N2 vaccine last year.
Investigation into the real amount of the unauthentic vaccines and the sales situation is underway.
Source: Xinhua News Agency - CEIS
Related Articles
- Russia Has Vaccines Against H5n1 Flu in Birds, Not Humans - Expert
- Baxter to Discuss Joint Production of Anti-Bird Flu Vaccine With Indonesia
- Novartis May Build U.S. Flu Vaccine Plant
- Vaccines Plant is to Change Hands Again
- Thailand to Build Bird Flu Vaccine Plant If Trials Succeed
- Vaccines for Everyone in Latest Bird Flu Plan
- Fight Avian Flu Among Birds First, UN Expert Urges
- Vaccine Plant to Open in Lancaster County, Pa.
- Chiron Reports Contamination in German Flu Vaccine Plant
 |
 |
User Comments (0)
RSS Feeds